Agreement expands Piramal’s payload-linker platform and bioconjugate abilities.

Eli Lilly and Company has announced plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Puerto Rico.

Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...

Thermo Fisher Scientific Inc. has agreed to acquire Clario Holdings Inc., a provider of digital endpoint data solutions for clinical trials, in a cash transaction valued at $8.875 billion.

The Pistoia Alliance, a global, not-for-profit alliance, is launching Phase 3 of its Chemistry, Manufacturing and Controls (CMC) Process Ontology project.

Apeloa Pharmaceutical, a global provider of technology-driven pharmaceutical manufacturing solutions, has passed its 20th U.S. FDA inspection.

Will transfer commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities.

Wheeler Bio has partnered with Mitsubishi Corporation to expand its commercial reach and business development activities across the Asia-Pacific region.

The certification highlights the company’s adherence to rigorous safety and traceability protocols within the cell and gene therapy supply chain.

Ajinomoto Bio-Pharma Services and Olon S.p.A. have entered into a strategic partnership to deliver drug substance manufacturing services.

Lifecore Biomedical, Inc., a an integrated CDMO, and PolyPeptide Laboratories, Inc ., a global peptide contract development and manufacturer, entered a collaboration agreement aimed at providing an ...

Catalent has introduced a new corporate brand, signaling a strategic shift aimed at enhancing customer service and reinforcing its role in global healthcare.